Unexpected prion phenotypes in experimentally transfused animals: predictive models for humans?

References

• Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–925.
   PubMed Web of Science ®Google Scholar
• Ghani AC, Ferguson NM, Donnelly CA, et al. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc Biol Sci. 1998;265:2443–2452.
   PubMed Web of Science ®Google Scholar
• EFSA. 2006. Quantitative assessment of the human BSE risk posed by gelatine with respect to residual BSE risk. Opinion of the scientific panel on biological hazards. EFSA J. 2006;312:1–29. (adopted on January 18, 2006).
   Google Scholar
• Turner ML, Ludlam CA. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol. 2009;144:14–23.
   PubMed Web of Science ®Google Scholar
• Urwin PJ, Mackenzie JM, Llewelyn CA, et al. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study. Vox Sang. 2016;110:310–316.
   PubMed Web of Science ®Google Scholar
• Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675.
   PubMedGoogle Scholar
• Mok T, Jaunmuktane Z, Joiner S, et al. Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP codon 129. N Engl J Med. 2017;376:292–294.
   PubMed Web of Science ®Google Scholar
• Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol. 2004;203:733–739.
   PubMed Web of Science ®Google Scholar
• Diack AB, Will RG, Manson JC. Public health risks from subclinical variant CJD. PLoS Pathog. 2017;13:e1006642.
   PubMed Web of Science ®Google Scholar
• Chen CC, Wang YH. Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. PLoS One. 2014;9:e94020.
   PubMed Web of Science ®Google Scholar
• Lasmezas CI, Comoy E, Hawkins S, et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet. 2005;365:781–783.
   PubMed Web of Science ®Google Scholar
• Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet. 2004;363:422–428.
   PubMed Web of Science ®Google Scholar
• Lescoutra-Etchegaray N, Jaffre N, Sumian C, et al. Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update. Transfusion (Paris). 2015;55:1231–1241.
   Web of Science ®Google Scholar
• Comoy EE, Mikol J, Jaffré N, et al. Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque. Nat Commun. 2017;8:1268.
   PubMed Web of Science ®Google Scholar
• Bons N, Mestre-Frances N, Belli P, et al. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci. 1999;96:4046–4051.
   PubMed Web of Science ®Google Scholar
• Ritchie DL, Gibson SV, Abee CR, et al. Blood transmission studies of prion infectivity in the squirrel monkey (Saimiri sciureus): the Baxter study. Transfusion. 2015;56:712–721.
   PubMed Web of Science ®Google Scholar
• Holznagel E, Yutzy B, Schulz-Schaeffer W, et al. Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates. Emerg Infect Dis. 2013;19:712–720.
   PubMed Web of Science ®Google Scholar
• Konold T, Arnold ME, Austin AR, et al. Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle - an update. BMC Res Notes. 2012;5:674.
   PubMedGoogle Scholar
• Hagenaars TJ, Ferguson NM, Donnelly CA, et al. Feed-borne transmission and case clustering of BSE. Proc R Soc B Biol Sci. 2000;267:205–215.
   PubMed Web of Science ®Google Scholar
• Berardi VA, Cardone F, Valanzano A, et al. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion (Paris). 2006;46:652–658.
   PubMed Web of Science ®Google Scholar
• Cervenakova L, Yakovleva O, McKenzie C, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion (Paris). 2003;43:1687–1694.
   PubMed Web of Science ®Google Scholar
• McDowell KL, Nag N, Franco Z, et al. Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent. Transfusion (Paris). 2015;55:405–412.
   Web of Science ®Google Scholar
• Lasmezas CI, Fournier JG, Nouvel V, et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt– jakob disease: implications for human health. Proc Natl Acad Sci USA. 2001;98:4142–4147.
   PubMed Web of Science ®Google Scholar
• Brown DA, Bruce ME, Fraser JR. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol. 2003;29:262–272.
   PubMed Web of Science ®Google Scholar
• Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 2002;21:6358–6366.
   PubMed Web of Science ®Google Scholar
• Aguilar-Calvo P, Bett C, Sevillano AM, et al. Generation of novel neuroinvasive prions following intravenous challenge. Brain Pathol Zurich Switz. 2018. doi: 10.1111/bpa.12598 .
   Google Scholar
• Yunoki M, Tanaka H, Urayama T, et al. Prion removal by nanofiltration under different experimental conditions. Biol J Int Assoc Biol Stand. 2008;36:27–36.
   Google Scholar
• Yunoki M, Tanaka H, Urayama T, et al. Infectious prion protein in the filtrate even after 15 nm filtration. Biol J Int Assoc Biol Stand. 2010;38:311–313.
   Google Scholar
• Cardone F, Simoneau S, Arzel A, et al. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in “spiked” albumin solutions. Transfusion (Paris). 2012;52:953–962.
   Web of Science ®Google Scholar
• Cardone F, Sowemimo-Coker S, Abdel-Haq H, et al. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in “spiked” human blood and red blood cells. Transfusion (Paris). 2014;54:990–995.
   Web of Science ®Google Scholar
• Tixador P, Herzog L, Reine F, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010;6:e1000859.
   PubMed Web of Science ®Google Scholar
• Hu MT, Ellis CM, Al-Chalabi A, et al. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950–951.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–1094.
   PubMed Web of Science ®Google Scholar
• Kim S-M, Kim S-J, Lee HJ, et al. Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord. 2017;10:265–289.
   PubMed Web of Science ®Google Scholar
• Vucic S, Tian D, Chong PS, et al. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain J Neurol. 2006;129:3384–3390.
   Google Scholar
• Katz JD, Ropper AH. Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol. 2000;57:355–361.
   PubMedGoogle Scholar
• Yang H, Liu M, Li X, et al. Neurophysiological differences between flail arm syndrome and amyotrophic lateral sclerosis. PLoS One [Internet]. 2015;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461255/
   Web of Science ®Google Scholar
• Kumar S, Mehta VK, Shukla R. Owl’s eye sign: A rare neuroimaging finding in flail arm syndrome. Neurology. 2015;84:1500.
   PubMed Web of Science ®Google Scholar
• Lebouteux M-V, Franques J, Guillevin R, et al. Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging. Eur J Neurol. 2014;21:1233–1241.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann NY Acad Sci. 2016;1366:20–39.
   PubMed Web of Science ®Google Scholar
• Bernard-Valnet R, Liblau RS, Vukusic S, et al. Neuromyelitis optica: a positive appraisal of seronegative cases. Eur J Neurol. 2015;22:1511–8,e82–83.
   PubMed Web of Science ®Google Scholar
• Chessa E, Piga M, Floris A, et al. Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series. Reumatismo. 2017;69:175–183.
   PubMed Web of Science ®Google Scholar
• Krasemann S, Mearini G, Kramer E, et al. BSE-associated prion-amyloid cardiomyopathy in primates. Emerg Infect Dis. 2013;19:985–988.
   PubMed Web of Science ®Google Scholar
• Mead S, Gandhi S, Beck J, et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013;369:1904–1914.
   PubMed Web of Science ®Google Scholar
• Gambetti P, Dong Z, Yuan J, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008;63:697–708.
   PubMed Web of Science ®Google Scholar
• Zou WQ, Puoti G, Xiao X, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol. 2010;68:162–172.
   PubMed Web of Science ®Google Scholar
• Benestad SL, Sarradin P, Thu B, et al. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec. 2003;153:202–208.
   PubMed Web of Science ®Google Scholar
• Lasmezas CI, Deslys JP, Robain O, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science. 1997;275:402–405.
   PubMed Web of Science ®Google Scholar
• Gonzalez L, Thorne L, Jeffrey M, et al. Infectious titres of sheep scrapie and bovine spongiform encephalopathy agents cannot be accurately predicted from quantitative laboratory test results. J Gen Virol. 2012;93:2518–2527.
   PubMed Web of Science ®Google Scholar
• Alibhai J, Blanco RA, Barria MA, et al. Distribution of misfolded prion protein seeding activity alone does not predict regions of neurodegeneration. PLoS Biol. 2016;14:e1002579.
   PubMed Web of Science ®Google Scholar
• Chételat G. Alzheimer disease: aβ-independent processes-rethinking preclinical AD. Nat Rev Neurol. 2013;9:123–124.
   PubMed Web of Science ®Google Scholar
• Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18:794–799.
   PubMed Web of Science ®Google Scholar